The ACSO Post: Elacestrant vs Endocrine Monotherapy in Advanced Breast Cancer: Phase III EMERALD Trial Shared By: contributorDecember 12, 2022 Virginia Kaklamani, MD, Medical Oncology, was quoted in this story. Read More Share This Article!
